Page last updated: 2024-11-05

trimetrexate and Body Weight

trimetrexate has been researched along with Body Weight in 2 studies

Trimetrexate: A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"Trimetrexate was administered to rats in an interrupted treatment regimen comparable to proposed human clinical treatment."1.28Chronic toxicity of the anticancer agent trimetrexate in rats. ( Dethloff, LA; Watkins, JR, 1992)
"Trimetrexate is a nonclassical folate antagonist that is active against a number of experimental murine and human tumor cell lines."1.28Toxicity of the anticancer folate antagonist trimetrexate in rats. ( Graziano, MJ; Kim, SN; MacDonald, JR; Watkins, JR, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dethloff, LA1
Watkins, JR2
Graziano, MJ1
Kim, SN1
MacDonald, JR1

Other Studies

2 other studies available for trimetrexate and Body Weight

ArticleYear
Chronic toxicity of the anticancer agent trimetrexate in rats.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1992, Volume: 19, Issue:1

    Topics: Animals; Body Weight; Bone Marrow; Bone Marrow Cells; Cecum; Dose-Response Relationship, Drug; Drug

1992
Toxicity of the anticancer folate antagonist trimetrexate in rats.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1992, Volume: 18, Issue:1

    Topics: Administration, Oral; Animals; Blood Cell Count; Body Weight; Bone Marrow; Bone Marrow Diseases; Eat

1992